Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Repurchase of Common Stock

Arbutus Biopharma Cp Repurchase of Common Stock Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Repurchase of Common Stock from 2011 to 2018.
  • Arbutus Biopharma Cp Repurchase of Common Stock for the quarter ending December 12, 2018 was $-1m a 90.91% decrease of -1m year over year
Other Cash Flow Metrics:
  • Arbutus Biopharma Cp Cash Flow from Operations for the quarter ending December 12, 2018 was $-17m a -16.70% increase of 3m year over year
  • Arbutus Biopharma Cp Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-36m a 63.34% decrease of -23m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Repurchase of Common Stock Data

12/2018$-1m
12/2017$0m
12/2015$0m
12/2012$0m
12/2011$-1m